Skip to Main content Skip to Navigation
Journal articles

Pulmonary hemosiderosis in children with Down syndrome: a national experience

Aurelia Alimi 1 Jessica Taytard 1 Rola Abou Taam 2 Véronique Houdouin 3, 4 Aude Forgeron 5, 6 Marc Lubrano Lavadera 7 Pierrick Cros 8, 9 Isabelle Gibertini 10 Jocelyne Derelle 11 Antoine Deschildre 12, 13 Caroline Thumerelle 12, 13 Ralph Epaud 14, 15 Philippe Reix 16, 17 Michael Fayon 18, 19 Sylvie Roullaud 20 Françoise Troussier 21, 22 Marie-Catherine Renoux 23 Jacques de Blic 2 Sophie Leyronnas 1 Guillaume Thouvenin 1, 24, 25 Caroline Perisson 1 Aimé Ravel 26 Annick Clement 1, 27, 25 Harriet Corvol 1, 24, 25 Nadia Nathan 1, 27, 25, * 
* Corresponding author
6 Service de Pédiatrie [CH Le Mans]
Centre Hospitalier Le Mans (CH Le Mans)
16 Evaluation et modélisation des effets thérapeutiques
Département biostatistiques et modélisation pour la santé et l'environnement [LBBE]
Abstract : BACKGROUND: Pulmonary hemosiderosis is a rare and complex disease in children. A previous study from the French RespiRare® network led to two important findings: 20% of the children presented with both pulmonary hemosiderosis and Down syndrome (DS), and at least one tested autoantibody was found positive in 50%. This study investigates the relationships between pulmonary hemosiderosis and DS.METHODS: Patients younger than 20 years old and followed for pulmonary hemosiderosis were retrieved from the RespiRare® database. Clinical, biological, functional, and radiological findings were collected, and DS and non-DS patients' data were compared.RESULTS: A total of 34 patients (22 girls and 12 boys) were included, among whom nine (26%) presented with DS. The mean age at diagnosis was 4.1 ± 3.27 years old for non-DS and 2.9 ± 3.45 years old for DS patients. DS patients tended to present a more severe form of the disease with an earlier onset, more dyspnoea at diagnosis, more frequent secondary pulmonary hypertension, and an increased risk of fatal evolution.CONCLUSIONS: DS patients have a higher risk of developing pulmonary hemosiderosis, and the disease seems to be more severe in this population. This could be due to the combination of an abnormal lung capillary bed with fragile vessels, a higher susceptibility to autoimmune lesions, and a higher risk of evolution toward pulmonary hypertension. A better screening for pulmonary hemosiderosis and a better prevention of hypoxia in DS paediatric patients may prevent a severe evolution of the disease.
Document type :
Journal articles
Complete list of metadata

Cited literature [34 references]  Display  Hide  Download
Contributor : Elizabeth Bernardo Connect in order to contact the contributor
Submitted on : Tuesday, June 26, 2018 - 9:13:23 AM
Last modification on : Saturday, September 24, 2022 - 2:36:04 PM
Long-term archiving on: : Wednesday, September 26, 2018 - 8:34:02 PM


Publisher files allowed on an open archive



Aurelia Alimi, Jessica Taytard, Rola Abou Taam, Véronique Houdouin, Aude Forgeron, et al.. Pulmonary hemosiderosis in children with Down syndrome: a national experience. Orphanet Journal of Rare Diseases, BioMed Central, 2018, 13 (1), pp.60. ⟨10.1186/s13023-018-0806-6⟩. ⟨inserm-01823418⟩



Record views


Files downloads